Since the year began, the marijuana industry has seemingly done no wrong. Following the legalization of recreational marijuana in Canada in mid-October, Wall Street is projecting that global weed sales could top $50 billion in roughly a decade's time. And with a compound double-digit annual growth rate comes some very lofty expectations from investors.

Months after marijuana sales became legal, public approval has reached a new high.

Close to 70 per cent of Lethbridge residents in the 18-to-29-year category now agree with the policy change, along with 57.2 per cent of all the men and women surveyed.

And a new study shows more than 90 per cent supported the drug’s use for medical purposes.

Public support for recreational use has increased from 43.9 per cent just four years ago, observes political scientist Faron Ellis. Under his supervision, students at Lethbridge College conducted a comprehensive “public policy” study in February.

It also found public support rising on several other issues in Lethbridge, including doctor-assisted death, same-sex marriage and a woman’s right to seek an abortion.

Serious marijuana money is starting to show up in Uruguay.

Almost six years after the South American country of 3.4 million people legalized cannabis, investors are betting Uruguay can become an export hub for medical marijuana as the industry expands around the world.

Silverpeak Life Sciences Uruguay Inc, one of the largest companies in the country’s nascent medical marijuana industry, is in talks with investment bankers to raise US$35 million this year to quadruple production and build a larger extraction lab in 2020, according to chief executive officer and U.S. cannabis investor Jordan Lewis.

"Our planned and desired expansion would be about 25 tons next year and that should push us above US$100 million in revenue," Lewis said.

Smoking high-potency marijuana every day could increase the chances of developing psychosis by nearly five times, according to the biggest-ever study to examine the impact of pot on psychotic disorder rates.

The research adds to previous studies that have found links between marijuana and mental health problems, but still does not definitively pinpoint marijuana as the cause.

Psychotic disorders -- in which people lose touch with reality -- are typically triggered by factors including genetics and the environment. But experts say the new study's findings have implications for jurisdictions legalizing marijuana, warning they should consider the potential impact on their mental health services.

A financing arrangement with a Big Canadian bank boosted a Canadian marijuana stock Tuesday. Here’s some small stocks making big moves on Tuesday, March 19, 2019 (as of 11:30 am EST):

Eve & Co Incorporated (TSXV:EVE), a Canadian marijuana stock, jumped 13% to $0.51 on Tuesday after announcing that it has entered into an $18.7 million construction facility with Royal Bank of Canada to fund the completion of the 780,000 sq. ft. expansion of Eve & Co’s greenhouse production facility located in Middlesex County, Ontario.

The cannabis stock sector is currently the hottest sector, and you can make big money by buying pot stocks.

However, while there are many companies that are trading publicly to choose from, you should be careful, because not all of them will survive in the long term.

To help you in your choice, I’m presenting three promising pot stocks that could boom in the coming months.

The owner of Thunder Hill Bakery in Grand Bay-Westfield is planning a reinvention of her signature cupcakes and muffins — with a cannabis twist.  

Jenn Guimond plans to open a second business, one that will showcase recipes using marijuana extracts that she makes at home.

Her new line of baked goods will include both the non-psychoactive CBD oil as well as THC, which does cause the "high." 

Sometimes she takes her cooking classes on the road and teaches neighbours what they can legally do in their own kitchens with their own pot.  

She says most of the interest is coming from people over 65. 

"It's other people's grandmothers," said Guimond, icing a tray of sugar-free, gluten-free, keto-friendly vanilla bean cupcakes infused with CBD. 

The marijuana industry is in the midst of an impressive comeback. After crashing post-legalization, the Canadian Marijuana Index is now up 53% year to date. One company that has been making headlines for all the right reasons is HEXO (TSX:HEXO).

In 2019, the company has surged almost 90% and is among the big winners of the year. In the past week alone, the company’s share price has jumped almost 10%. Why? It has been a transformative week for the company.

Prior to releasing strong second-quarter results, the company announced a deal to acquire Newstrike Brands.

Peter Horvath does not particularly like the idea of a cannabis cafe. He does not like a lounge either — or a bar, or any place to buy and sit and use cannabis.

“It sounds like a repulsive experience to me,” the chief executive of Green Growth Brands, a cannabis producer with a burgeoning retail division, said over the phone from Columbus, Ohio.

Low-margin cafes and smokey consumption lounges, Horvath said, are just impractical. “So how do you make money?” he asked. “It’s like saying, ‘I want to own bars.’ Have you ever watched a Bar Rescue episode? What a mess bars are.”

The marijuana industry is growing like a weed. According to various Wall Street prognostications, the global cannabis industry could be generating upwards of $50 billion to $75 billion in annual sales roughly one decade from now. That's a boatload of cash, and all the more reason for pot growers to double down on capacity expansion.

Although there are 11 growers that are currently on pace for more than 100,000 kilograms in peak annual output, according to their respective management teams, none stands out more than Alberta-based Aurora Cannabis (NYSE:ACB).